• The leading speciality consultancy appoints Sunalini Mathew as Director—Health Initiatives

• Begins the new FY with acquisition of marquee clients from pharmaceuticals, healthcare, and wellness sectors

New Delhi, May 25th, 2016:  To strengthen its delivery of super-specialised health communication solutions, Teamwork Health, India’s premier speciality media engagement and public awareness firm for health and wellness sector, has taken on board reputed strategic communicators and revamped its bouquet of services.

Teamwork Health, a speciality division of India’s media and public relations major Teamwork Communications Group, has appointed Ms Sunalini Mathew as Director—Health Initiatives. Ms Mathew, former Managing Editor of Prevention and Deputy Editor of Reader’s Digest (both India Today Group magazines), has over 12 years’ experience in healthcare and lifestyle writing.

Teamwork Communications Group had recently announced the joining of Mr Askari Zaidi, a media and communication veteran who had worked with The Times of India, Hindustan Times and Indian Express, in various senior editorial positions for over two decades before switching over to corporate communications to manage the brand building requirements of leading corporates such as Reliance Anil Ambani Group, Jindal Steel, and Jaypee Group.

Teamwork Health has had in its fold Dr Bobby John, a global healthcare policy expert and co-founder of policy advocacy group Global Health Advocates, as an advisor for quite some time. With the recent joining of Askari Zaidi and Sunalini Mathew, Teamwork Communication Group has acquired remarkable capability in healthcare communication that can have a life-changing impact.

“It takes specialized knowledge and understanding of the domain to make a mark in a crowded market place. We have worked diligently over the years to acquire talent that is capable of delivering innovative campaigning modules that sets us apart in healthcare communication,” said Mr Kamal Narayan Omer, Managing Director, Teamwork Communications Group.

“Teamwork Health has built impeccable capacity in undertaking massive public awareness campaigns on various health issues affecting our vast population. The campaigns involve rigorous research, creativity, and innovative storytelling capacities that make a measurable impact. I am really excited to be part of Teamwork that works not just to increase business outcomes but also strives to bring about life-changing experiences for people,” said Ms Mathew on joining Teamwork.

Teamwork Health provides communication solutions to companies operating in the healthcare, pharmaceutical, wellness, and beauty businesses, by devising messages that are simple yet creative, messages that are strong and leave a lasting impact on people’s mind. “We have successfully managed a wide array of healthcare campaigns over the years including country-wide awareness initiatives on cerebral palsy, Alzheimer’s disease, cancer, glaucoma, and organ donation, among others,” said Mr Omer.

Teamwork has provided impactful services to various healthcare companies and organizations such as Allergan Healthcare India Pvt. Ltd., India Medtronic, BD India, Cipla, Core Diagnostics, Diabetacare, Mylan, St. Jude, Essilor, Indian Spinal Injuries Centre, Columbia Asia Hospitals, Paras Hospitals and Panacea Biotec.

It is in recognition of Teamwork’s pre-eminent position in the healthcare communication sphere that several prominent organizations have showered it with accolades, the latest being the Best Agency Servicing for Healthcare Industry Award presented at the prestigious CMO Asia Healthcare Excellence Awards function held at Singapore last August.

To be able to cater to the diverse requirements of leading healthcare companies, Teamwork has strengthened its bouquet of services to include Strategic Media Relations, Advocacy Relations, Public & Patient Disease Awareness services, KOL/Influencer Relations, Issue/Crisis Management, Patient Forums/Communities, Specialized Content & Design, Customised Events, Outreach campaigns, Spokesperson Training, and Digital & Social Media.

Teamwork has also worked out the following exclusive products for its clients:

HospitalPR.pro: A highly focused and specialized communication solution for hospitals and healthcare providers.

PharmaPR.pro: A customized solution for the pharma and life sciences industry.

WellnessPR.pro: A bundle of integrated services that focuses on a gamut of sectors that plays a role in educating people on overall well-being and healthy lifestyle.

PatienteduPR.pro: A specialized service to drive high-impact education and awareness campaigns for patients and caregivers on prevention and treatment of various diseases and healthcare issues.

The post Teamwork Health strengthens its strategic communication capabilities, adds new services and talent appeared first on Core Sector Communique.

Advanced DES with CoreWire Technology That Allows for Thinner, Stronger Struts, Enhanced Deliverability and Radiopacity without Compromising Structural Strength

New Delhi, India – 22 July 2015 – Optimizing the treatment of coronary artery disease with a new foundation for future stent innovations, Medtronic plc. (NYSE: MDT) today announced launch of the Resolute Onyx Drug-Eluting Stent (DES) in India.

“With the new Core Wire technology, the Resolute Onyx DES sets a new standard for durable polymer DES. It is a revolution in stent technology that allows for improved deliverability in extremely tortuous arteries and enhanced conformability because of the flexible design, greater radiopacity and thinner struts”, said Shamik Dasgupta Vice President Cardiac and Vascular Group, India Medtronic.

Built on the proven clinical performance and superior deliverability of the Resolute Integrity DES, the Resolute Onyx DES is the first stent to feature a new advancement called CoreWire Technology that allows it to have a denser core metal wrapped in a cobalt alloy outer layer. This new technology enables increased radiopacity (i.e., visibility during the procedure). Radiopacity is a very important feature and refers to a metal’s ability in being opaque to one or another form of radiation, such as X-rays. Radiopaque objects block radiation rather than allow it to pass through making them visible on X-rays.

Resolute Onyx DES has thinner struts to help improve deliverability without compromising radial and longitudinal strength.

Resolute Onyx DES features PowerTrac technology, a new delivery system that was introduced earlier this year with the NC Euphora Noncompliant Balloon Dilatation Catheter. The result is a revolutionary new DES that provides superior deliverability which means it is exceptionally easy to navigate the stent through the tortuous and narrowed arterial segment that requires treatment. This makes it easier to address the needs of patients with complex cases who require better deliverability and tracking. This technology further reduces the force that is required to navigate the stent into the patient’s anatomy thereby giving enhanced procedural confidence.

CoreWire Technology is the next new DES advancement after Continuous Sinusoid Technology (CST), which was previously introduced with the Resolute Integrity DES and the Integrity bare-metal stent. CST is a method of stent manufacturing that molds one single strand of wire into a sinusoidal wave enabling a continuous range of motion.

“Deliverability of a coronary stent has always been the mainstay in providing acute results during PTCA. Through an innovative Medtronic-developed process, Resolute Onyx DES is manufactured from a single strand of core wire into a sinusoidal wave form that provides a fluid range of motion without compromising the structural strength”, said Managing Director & Vice President South Asia for India Medtronic, Mr. Milind Shah.

Resolute Onyx expands Medtronic’s interventional cardiology portfolio of medical devices across Coronary, Renal Denervation and TAVI, and is the latest in a series of 12 new product introductions planned over the next two years.

In collaboration with leading clinicians, researchers and scientists, Medtronic offers the broadest range of innovative medical technology for the interventional and surgical treatment of cardiovascular disease and cardiac arrhythmias. The company strives to offer products and services that deliver clinical and economic value to healthcare consumers and providers worldwide.

With ~ 61.5 Mn Coronary Heart Disease (CHD) patients in 2015, India becomes one of the largest contributors of CHD patients in the world. By 2020, India is expected to have the largest disease burden in the world and shall account for 1/3rd of the deaths. Approximately 9-10% of the CHD patients suffer from an acute coronary event, accounting for 4-5 Mn cases of Acute Coronary Syndrome (ACS) every year ¹. Of this only ~ 1.6 Mn patients are treated with cardiac stents over the past 10 years. Cardiac stent therapy penetration in India is at 2.6% of the diseased population. ²

ABOUT MEDTRONIC

Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is the global leader in medical technology –– alleviating pain, restoring health and extending life for millions of people around the world.

Medtronic began its operations in India in the year 1979. Headquartered at Solitaire Corporate Park in Mumbai, it has offices at Ahmedabad, Bengaluru, Chennai, Cochin, Dhaka, Gurgaon, Hyderabad, Kolkata, New Delhi, Pune and Vadodara.

The post Medtronic LAUNCHES Resolute onyx™ Drug-Eluting stent IN India appeared first on Core Sector Communique.